R&D

R&D Center

Will become a leading company in the active pharmaceutical ingredient (API) industry.

R&D

We are committed to R&D with the goal of developing and producing world-class active pharmaceutical ingredients.

Since our establishment, HSBio R&D Center has developed proprietary technologies and expanded research capabilities through intensive R&D investment, top-tier researchers, and collaboration with leading universities.
We have supplied the highest quality active pharmaceutical ingredients meeting KP, USP, EP, and JP pharmacopeias to domestic and Japanese markets.

  • Synthetic research

    • Development of synthetic methods for active pharmaceutical ingredients (APIs) and intermediates
    • Development of new drugs by improving raw pharmaceutical ingredients through the introduction of new salts
    • Development of functional raw materials derived from natural products
    • Development of a customized raw pharmaceutical manufacturing method for each client
  • Analytical research

    • CTD material preparation
    • Establishment of standards and test methods for raw pharmaceutical ingredients (API)
    • Method development and validation
    • Impurity profile research and standard form establishment
    • 기술영업
  • Technical sales

    • Providing differentiated APIs and technical services to domestic and international clients based on our core original technologies.
  • CDMO

    • Providing domestic and international CDMO business services
    • Establishing an optimized mass production process and producing high-quality pharmaceuticals
    • Preparation of CTD data for GMP production and license registration